nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—MPO—Cisplatin—peripheral nervous system neoplasm	0.263	0.372	CbGbCtD
Nabumetone—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.0908	0.128	CbGbCtD
Nabumetone—PTGS2—Etoposide—peripheral nervous system neoplasm	0.0892	0.126	CbGbCtD
Nabumetone—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.086	0.122	CbGbCtD
Nabumetone—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0753	0.107	CbGbCtD
Nabumetone—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0688	0.0973	CbGbCtD
Nabumetone—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0336	0.0476	CbGbCtD
Nabumetone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000284	0.000967	CcSEcCtD
Nabumetone—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000283	0.000965	CcSEcCtD
Nabumetone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000283	0.000965	CcSEcCtD
Nabumetone—Rash—Topotecan—peripheral nervous system neoplasm	0.000283	0.000965	CcSEcCtD
Nabumetone—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000283	0.000964	CcSEcCtD
Nabumetone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000283	0.000964	CcSEcCtD
Nabumetone—Cough—Etoposide—peripheral nervous system neoplasm	0.000282	0.00096	CcSEcCtD
Nabumetone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000282	0.00096	CcSEcCtD
Nabumetone—Headache—Topotecan—peripheral nervous system neoplasm	0.000281	0.000958	CcSEcCtD
Nabumetone—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.000957	CcSEcCtD
Nabumetone—Rash—Tretinoin—peripheral nervous system neoplasm	0.000281	0.000957	CcSEcCtD
Nabumetone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000281	0.000956	CcSEcCtD
Nabumetone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000281	0.000956	CcSEcCtD
Nabumetone—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00028	0.000956	CcSEcCtD
Nabumetone—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000279	0.000953	CcSEcCtD
Nabumetone—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000279	0.000951	CcSEcCtD
Nabumetone—Headache—Tretinoin—peripheral nervous system neoplasm	0.000279	0.000951	CcSEcCtD
Nabumetone—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000279	0.00095	CcSEcCtD
Nabumetone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000278	0.000948	CcSEcCtD
Nabumetone—Constipation—Vincristine—peripheral nervous system neoplasm	0.000278	0.000948	CcSEcCtD
Nabumetone—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000948	CcSEcCtD
Nabumetone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000278	0.000947	CcSEcCtD
Nabumetone—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000277	0.000945	CcSEcCtD
Nabumetone—Rash—Melphalan—peripheral nervous system neoplasm	0.000277	0.000945	CcSEcCtD
Nabumetone—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000277	0.000944	CcSEcCtD
Nabumetone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.000941	CcSEcCtD
Nabumetone—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000274	0.000934	CcSEcCtD
Nabumetone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000273	0.000932	CcSEcCtD
Nabumetone—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000272	0.000925	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000922	CcSEcCtD
Nabumetone—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000268	0.000914	CcSEcCtD
Nabumetone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000268	0.000914	CcSEcCtD
Nabumetone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000909	CcSEcCtD
Nabumetone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.000909	CcSEcCtD
Nabumetone—Nausea—Topotecan—peripheral nervous system neoplasm	0.000267	0.000909	CcSEcCtD
Nabumetone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000266	0.000906	CcSEcCtD
Nabumetone—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000906	CcSEcCtD
Nabumetone—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000266	0.000905	CcSEcCtD
Nabumetone—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000265	0.000902	CcSEcCtD
Nabumetone—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000265	0.000902	CcSEcCtD
Nabumetone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000263	0.000898	CcSEcCtD
Nabumetone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000261	0.00089	CcSEcCtD
Nabumetone—Nausea—Melphalan—peripheral nervous system neoplasm	0.000261	0.00089	CcSEcCtD
Nabumetone—Asthma—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000885	CcSEcCtD
Nabumetone—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000885	CcSEcCtD
Nabumetone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000258	0.00088	CcSEcCtD
Nabumetone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000258	0.000879	CcSEcCtD
Nabumetone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000257	0.000876	CcSEcCtD
Nabumetone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000257	0.000876	CcSEcCtD
Nabumetone—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000875	CcSEcCtD
Nabumetone—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000256	0.000874	CcSEcCtD
Nabumetone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000255	0.000868	CcSEcCtD
Nabumetone—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000868	CcSEcCtD
Nabumetone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000862	CcSEcCtD
Nabumetone—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000253	0.000862	CcSEcCtD
Nabumetone—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000251	0.000856	CcSEcCtD
Nabumetone—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000853	CcSEcCtD
Nabumetone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00025	0.000852	CcSEcCtD
Nabumetone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000249	0.000849	CcSEcCtD
Nabumetone—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000249	0.000847	CcSEcCtD
Nabumetone—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000839	CcSEcCtD
Nabumetone—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000828	CcSEcCtD
Nabumetone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000242	0.000825	CcSEcCtD
Nabumetone—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000819	CcSEcCtD
Nabumetone—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000819	CcSEcCtD
Nabumetone—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00024	0.000817	CcSEcCtD
Nabumetone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.000814	CcSEcCtD
Nabumetone—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000808	CcSEcCtD
Nabumetone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000237	0.000808	CcSEcCtD
Nabumetone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000237	0.000806	CcSEcCtD
Nabumetone—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000236	0.000805	CcSEcCtD
Nabumetone—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000803	CcSEcCtD
Nabumetone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000801	CcSEcCtD
Nabumetone—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000235	0.0008	CcSEcCtD
Nabumetone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000798	CcSEcCtD
Nabumetone—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000234	0.000798	CcSEcCtD
Nabumetone—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.000798	CcSEcCtD
Nabumetone—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000233	0.000795	CcSEcCtD
Nabumetone—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000794	CcSEcCtD
Nabumetone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000231	0.000789	CcSEcCtD
Nabumetone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.000787	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000782	CcSEcCtD
Nabumetone—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.000782	CcSEcCtD
Nabumetone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000229	0.000781	CcSEcCtD
Nabumetone—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000776	CcSEcCtD
Nabumetone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000227	0.000775	CcSEcCtD
Nabumetone—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000227	0.000774	CcSEcCtD
Nabumetone—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000769	CcSEcCtD
Nabumetone—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000226	0.000769	CcSEcCtD
Nabumetone—Constipation—Etoposide—peripheral nervous system neoplasm	0.000225	0.000768	CcSEcCtD
Nabumetone—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000766	CcSEcCtD
Nabumetone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000223	0.000761	CcSEcCtD
Nabumetone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000223	0.000758	CcSEcCtD
Nabumetone—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000221	0.000752	CcSEcCtD
Nabumetone—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000747	CcSEcCtD
Nabumetone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000745	CcSEcCtD
Nabumetone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000741	CcSEcCtD
Nabumetone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000217	0.00074	CcSEcCtD
Nabumetone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000739	CcSEcCtD
Nabumetone—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000216	0.000737	CcSEcCtD
Nabumetone—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000736	CcSEcCtD
Nabumetone—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000734	CcSEcCtD
Nabumetone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000215	0.000734	CcSEcCtD
Nabumetone—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000215	0.000733	CcSEcCtD
Nabumetone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000215	0.000731	CcSEcCtD
Nabumetone—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.000725	CcSEcCtD
Nabumetone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.000725	CcSEcCtD
Nabumetone—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000724	CcSEcCtD
Nabumetone—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000212	0.000722	CcSEcCtD
Nabumetone—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000211	0.000721	CcSEcCtD
Nabumetone—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000718	CcSEcCtD
Nabumetone—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000209	0.000713	CcSEcCtD
Nabumetone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000712	CcSEcCtD
Nabumetone—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000712	CcSEcCtD
Nabumetone—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.000712	CcSEcCtD
Nabumetone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000208	0.00071	CcSEcCtD
Nabumetone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000208	0.00071	CcSEcCtD
Nabumetone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000208	0.000708	CcSEcCtD
Nabumetone—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000207	0.000705	CcSEcCtD
Nabumetone—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000206	0.000703	CcSEcCtD
Nabumetone—Rash—Vincristine—peripheral nervous system neoplasm	0.000205	0.000699	CcSEcCtD
Nabumetone—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000205	0.000698	CcSEcCtD
Nabumetone—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000696	CcSEcCtD
Nabumetone—Headache—Vincristine—peripheral nervous system neoplasm	0.000204	0.000694	CcSEcCtD
Nabumetone—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.000683	CcSEcCtD
Nabumetone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000683	CcSEcCtD
Nabumetone—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000681	CcSEcCtD
Nabumetone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000197	0.000671	CcSEcCtD
Nabumetone—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00067	CcSEcCtD
Nabumetone—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000194	0.000662	CcSEcCtD
Nabumetone—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000661	CcSEcCtD
Nabumetone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000659	CcSEcCtD
Nabumetone—Nausea—Vincristine—peripheral nervous system neoplasm	0.000193	0.000658	CcSEcCtD
Nabumetone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000655	CcSEcCtD
Nabumetone—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000189	0.000644	CcSEcCtD
Nabumetone—Chills—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000636	CcSEcCtD
Nabumetone—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000186	0.000635	CcSEcCtD
Nabumetone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000633	CcSEcCtD
Nabumetone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000632	CcSEcCtD
Nabumetone—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000626	CcSEcCtD
Nabumetone—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000183	0.000623	CcSEcCtD
Nabumetone—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.00062	CcSEcCtD
Nabumetone—Rash—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000618	CcSEcCtD
Nabumetone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000181	0.000617	CcSEcCtD
Nabumetone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00018	0.000614	CcSEcCtD
Nabumetone—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000611	CcSEcCtD
Nabumetone—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000608	CcSEcCtD
Nabumetone—Tension—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000605	CcSEcCtD
Nabumetone—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000599	CcSEcCtD
Nabumetone—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000174	0.000594	CcSEcCtD
Nabumetone—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000588	CcSEcCtD
Nabumetone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000586	CcSEcCtD
Nabumetone—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000171	0.000582	CcSEcCtD
Nabumetone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000579	CcSEcCtD
Nabumetone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000572	CcSEcCtD
Nabumetone—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000168	0.000571	CcSEcCtD
Nabumetone—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00057	CcSEcCtD
Nabumetone—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000567	CcSEcCtD
Nabumetone—Rash—Etoposide—peripheral nervous system neoplasm	0.000166	0.000566	CcSEcCtD
Nabumetone—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000166	0.000566	CcSEcCtD
Nabumetone—Headache—Etoposide—peripheral nervous system neoplasm	0.000165	0.000562	CcSEcCtD
Nabumetone—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000562	CcSEcCtD
Nabumetone—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00056	CcSEcCtD
Nabumetone—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000556	CcSEcCtD
Nabumetone—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000554	CcSEcCtD
Nabumetone—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000554	CcSEcCtD
Nabumetone—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000553	CcSEcCtD
Nabumetone—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000552	CcSEcCtD
Nabumetone—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000545	CcSEcCtD
Nabumetone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000542	CcSEcCtD
Nabumetone—Cough—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000538	CcSEcCtD
Nabumetone—Nausea—Etoposide—peripheral nervous system neoplasm	0.000156	0.000533	CcSEcCtD
Nabumetone—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000532	CcSEcCtD
Nabumetone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000529	CcSEcCtD
Nabumetone—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000527	CcSEcCtD
Nabumetone—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000524	CcSEcCtD
Nabumetone—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000523	CcSEcCtD
Nabumetone—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000519	CcSEcCtD
Nabumetone—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000515	CcSEcCtD
Nabumetone—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000513	CcSEcCtD
Nabumetone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000513	CcSEcCtD
Nabumetone—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000512	CcSEcCtD
Nabumetone—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000511	CcSEcCtD
Nabumetone—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000507	CcSEcCtD
Nabumetone—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000504	CcSEcCtD
Nabumetone—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000503	CcSEcCtD
Nabumetone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000503	CcSEcCtD
Nabumetone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000502	CcSEcCtD
Nabumetone—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000498	CcSEcCtD
Nabumetone—Shock—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000495	CcSEcCtD
Nabumetone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000493	CcSEcCtD
Nabumetone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000493	CcSEcCtD
Nabumetone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000487	CcSEcCtD
Nabumetone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000484	CcSEcCtD
Nabumetone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00048	CcSEcCtD
Nabumetone—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.00048	CcSEcCtD
Nabumetone—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000475	CcSEcCtD
Nabumetone—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.00047	CcSEcCtD
Nabumetone—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000466	CcSEcCtD
Nabumetone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000466	CcSEcCtD
Nabumetone—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000458	CcSEcCtD
Nabumetone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000456	CcSEcCtD
Nabumetone—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000455	CcSEcCtD
Nabumetone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000452	CcSEcCtD
Nabumetone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.00045	CcSEcCtD
Nabumetone—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000449	CcSEcCtD
Nabumetone—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000447	CcSEcCtD
Nabumetone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000444	CcSEcCtD
Nabumetone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000443	CcSEcCtD
Nabumetone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000438	CcSEcCtD
Nabumetone—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000434	CcSEcCtD
Nabumetone—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000126	0.00043	CcSEcCtD
Nabumetone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000421	CcSEcCtD
Nabumetone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000418	CcSEcCtD
Nabumetone—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000415	CcSEcCtD
Nabumetone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000415	CcSEcCtD
Nabumetone—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000414	CcSEcCtD
Nabumetone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000412	CcSEcCtD
Nabumetone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00041	CcSEcCtD
Nabumetone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000405	CcSEcCtD
Nabumetone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000401	CcSEcCtD
Nabumetone—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000117	0.0004	CcSEcCtD
Nabumetone—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000398	CcSEcCtD
Nabumetone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000398	CcSEcCtD
Nabumetone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000398	CcSEcCtD
Nabumetone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000384	CcSEcCtD
Nabumetone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000381	CcSEcCtD
Nabumetone—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000371	CcSEcCtD
Nabumetone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.00037	CcSEcCtD
Nabumetone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000368	CcSEcCtD
Nabumetone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000368	CcSEcCtD
Nabumetone—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000361	CcSEcCtD
Nabumetone—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000356	CcSEcCtD
Nabumetone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000344	CcSEcCtD
Nabumetone—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000343	CcSEcCtD
Nabumetone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	9.8e-05	0.000334	CcSEcCtD
Nabumetone—Dizziness—Epirubicin—peripheral nervous system neoplasm	9.77e-05	0.000333	CcSEcCtD
Nabumetone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000329	CcSEcCtD
Nabumetone—Vomiting—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.00032	CcSEcCtD
Nabumetone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000319	CcSEcCtD
Nabumetone—Rash—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000317	CcSEcCtD
Nabumetone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.000317	CcSEcCtD
Nabumetone—Headache—Epirubicin—peripheral nervous system neoplasm	9.25e-05	0.000315	CcSEcCtD
Nabumetone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	9.04e-05	0.000308	CcSEcCtD
Nabumetone—Nausea—Epirubicin—peripheral nervous system neoplasm	8.77e-05	0.000299	CcSEcCtD
Nabumetone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.000296	CcSEcCtD
Nabumetone—Rash—Doxorubicin—peripheral nervous system neoplasm	8.62e-05	0.000294	CcSEcCtD
Nabumetone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000293	CcSEcCtD
Nabumetone—Headache—Doxorubicin—peripheral nervous system neoplasm	8.56e-05	0.000292	CcSEcCtD
Nabumetone—Nausea—Doxorubicin—peripheral nervous system neoplasm	8.12e-05	0.000277	CcSEcCtD
